Cross-Reaction between Gliadin and Different Food and Tissue Antigens


A subgroup of coeliac disease patients continues to experience symptoms even on a gluten-free diet (GFD). We attempted to determine whether these symptoms could be due to either cross-contamination with gluten-containing foods or cross-reactivity between α-gliadin and non-gluten foods consumed on a GFD. We measured the reactivity of affinity-purified polyclonal and monoclonal α-gliadin 33-mer peptide antibodies against gliadin and additional food antigens commonly consumed by patients on a GFD using ELISA and dot-blot. We also examined the immune reactivity of these antibodies with various tissue antigens. We observed significant immune reactivity when these antibodies were applied to cow’s milk, milk chocolate, milk butyrophilin, whey protein, casein, yeast, oats, corn, millet, instant coffee and rice. To investigate whether there was cross-reactivity between α-gliadin antibody and different tissue antigens, we measured the degree to which this antibody bound to these antigens. The most significant binding occurred with asialoganglioside, hepatocyte, glutamic acid decarboxylase 65, adrenal 21-hydroxylase, and various neural antigens. The specificity of anti-α-gliadin binding to different food and tissue antigens was demonstrated by absorption and inhibition studies. We also observed significant cross-reactivity between α-gliadin 33-mer and various food antigens, but some of these reactions were associated with the contamination of non-gluten foods with traces of gluten. The consumption of cross-reactive foods as well as gluten-contaminated foods may be responsible for the continuing symptoms presented by a subgroup of patients with coeliac disease. The lack of response of some CD patients may also be due to antibody cross-reactivity with non-gliadin foods. These should then be treated as gluten-like peptides and should also be excluded from the diet when the GFD seems to fail.

Share and Cite:

A. Vojdani and I. Tarash, "Cross-Reaction between Gliadin and Different Food and Tissue Antigens," Food and Nutrition Sciences, Vol. 4 No. 1, 2013, pp. 20-32. doi: 10.4236/fns.2013.41005.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] D. H. Dewar and P. J.Ciclitira, “Clinical Features and Diagnosis of Coeliac Disease,” Gastoenterology, Vol. 128, No. 4, 2005, pp. S19-S24. doi:10.1053/j.gastro.2005.02.010
[2] V. Verhasselt, “Oral Tolerance in Neonates: From Basics to Potential Prevention of Allergic Disease,” Mucosal Immunology, Vol. 3, No. 4, 2010, pp. 326-333. doi:10.1038/mi.2010.25
[3] A. Vojdani, “The Characterization of the Repertoire of Wheat Antigens and Peptides Involved in the Humoral Immune Responses in Patients with Gluten Sensitivity and Crohn’s Disease,” ISRN Allergy, Vol. 2011, 2011, Article ID: 950104.
[4] M. Hadjivassiliou, C. A. Williamson and N. Woodroofe, “The Immunology of Gluten Sensitivity: Beyond the Gut,” Trends in Immunology, Vol. 25, No. 11, 2004, pp. 578-582. doi:10.1016/
[5] P. H. R. Green and C. Cellier, “Coeliac Disease,” New England Journal of Medicine, Vol. 357, No. 17, 2007, pp. 1731-1743. doi:10.1056/NEJMra071600
[6] A. Lanzini, F. Lanzarotto, V. Villanacci, A. Mora, S. Bertolazzi, et al., “Complete Recovery of Intestinal Mucosa Occurs Very Rarely In Adult Coeliac Patients Despite Adherence to Gluten-Free Diet,” Alimentary Pharmacologyand Therapeutics, Vol. 29, No. 12, 2009, pp. 1299-1308. doi:10.1111/j.1365-2036.2009.03992.x
[7] M. Hadjivassiliou, A. K. Chattopadhyay, G. A. B. Davies-Jones, A. Gibson, R. A. Grünewald, et al., “Neuromuscular Disorder as a Presenting Feature of Coeliac Disease,” Journal of Neurology, Neurosurgery and Psychiatry with Practical Neurology, Vol. 63, No. 6, 1997, pp. 770-775. doi:10.1136/jnnp.63.6.770
[8] G. Zanoni, R. Navone, C. Lunardi, G. Tridente, C. Bason, et al., “In Coeliac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-Like Receptor 4 and Induces Activation of Monocytes,” Public Library of Science Medicine, Vol. 3, No. 9, 2006, pp. 1637-1652.
[9] A. G. Pockley, “Heat Shock Proteins as Regulators of the Immune Response,” Lancet, Vol. 362, No. 9382, 2003, pp. 469-476. doi:10.1016/S0140-6736(03)14075-5
[10] M. Amagai, “Desmoglein as a Target in Autoimmunity and Infection,” Journal of the American Academy of Dermatology, Vol. 48, No. 2, 2003, pp. 244-252. doi:10.1067/mjd.2003.7
[11] J. Laporte, F. Beder, A. Bolino and J. L. Mandel, “Myotubularins, a Large Disease-Associated Family of Cooperating Catalytically Active and Inactive Phosphoinositides Phosphatases,” Human Molecular Genetics, Vol. 12, No. R2, 2003, pp. R285-R292. doi:10.1093/hmg/ddg273
[12] S. E. Blutt, S. E. Crawford, K. L. Warfield, D. E. Lewis, M. K. Estes, et al., “The VP7 Outer Capsid Protein of Rotavirus Induces Polyclonal B-Cell Activation,” Journal of Virology, Vol. 78, No. 13, 2004, pp. 6974-6981. doi:10.1128/JVI.78.13.6974-6981.2004
[13] G. Kristjansson, P. Venge and R. Hallgren, “Mucosal Reactivity to Cow’s Milk Protein in Coeliac Disease,” Clinicaland Experimental Immunology, Vol. 147, No. 3, 2007, pp. 449-455. doi:10.1111/j.1365-2249.2007.03298.x
[14] A. Fasano, “Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer,” Physiological Reviews, Vol. 91, No. 1, 2011, pp. 151-175. doi:10.1152/physrev.00003.2008
[15] A. Vojdani, “Detection of IgE, IgG, IgA and IgM Antibodies against Raw and Processed Food Antigens,” Nutrition and Metabolism, Vol. 6, 2009, p. 22. doi:10.1186/1743-7075-6-22
[16] S. Husby, S. Koletzko, I. R. Korponay-Szabo, et al., “European Society for Pediatric Gastroenterology Hepatology and Nutrition Guidelines for the Diagnosis of Coeliac Disease,” Journal of Pediatric Gastroenterology and Nutrition, Vol. 54, No. 1, 2012, pp. 136-160. doi:10.1097/MPG.0b013e31821a23d0
[17] C. Mitea, Y. Kooy-Winkelaar, P. V. Veelen, A. de Ru, J. W. Drijfhout, et al., “Fine Specificity of Monoclonal Antibodies against Coeliac Disease—Including Peptides in the Gluteome,” The American Journal of Clinical Nutrition, Vol. 88, No. 4, 2008, pp. 1057-1066.
[18] M. Darewicz, J. Dziuba and P. Minkiewicz, “Computational Characterization and Identification of Peptides for In Silico Detection of Potentially Coeliac-Toxic Proteins,” Food Science and Technology International, Vol. 13, No. 2, 2007, pp. 125-133. doi:10.1177/1082013207077954
[19] C. Berti, C. Trovat, M. T. Bardella and F. Forlani, “IgA Anti-Gliadin Antibody Immunoreactivity to Food Proteins,” Food and Agricultural Immunology, Vol. 15, No. 3-4, 2003, pp. 217-223. doi:10.1080/09540100400003204
[20] F. Cabrera-Chavez and A. M. Calderon de la Barca, “Bovine Milk Intolerance in Celiac Disease Is Related to IgA Reactivity to and Casein,” Nutrition, Vol. 25, No. 6, 2009, pp. 715-716. doi:10.1016/j.nut.2009.01.006
[21] T. Thompson, “Gluten Contamination of Commercial Oat Products in the United States,” New England Journal of Medicine, Vol. 351, No. 19, 2004, pp. 2021-2022. doi:10.1056/NEJM200411043511924
[22] H. Arentz-Hansen, B. Fleckenstin, O. Mulberg, H. Scott, F. Koning, et al., “The Molecular Basis for Oats Intolerance in Patients with Celiac Disease,” Public Library of Science Medicine, Vol. 1, No. 1, 2004, p. e1.
[23] I. Comino, A. Real, L. de Lorenzo, H. Cornell, M. A. Lopez-Casado, et al., “Diversity in Oat Potential Immunogenicity: Basis for the Selection of Oat Varieties with No Toxicity in Coeliac Disease,” Gut, Vol. 60, No. 7, 2011, pp. 915-922. doi:10.1136/gut.2010.225268
[24] U. Srinivasan, E. Jones, J. Carolan and C. Feighery, “Immunohistochemical Analysis of Coeliac Mucosa Following Ingestion of Oats,” Clinincal and Experimental Immunology, Vol. 144, No. 2, 2006, pp. 197-203. doi:10.1111/j.1365-2249.2006.03052.x
[25] W. R. Bernard and C. R. Sommerville, “Coidentity of Putative Amylase Inhibitors from Barley and Finger Millet with Phospholipid Transfer Protein Inferred from Amino Acid Sequence Homology,” Archives of Biochemisgtry and Biophysics, Vol. 269, No. 2, 1989, pp. 695-697. doi:10.1016/0003-9861(89)90154-9
[26] E. A. Pastorello, C. Compei, V. Pravettoni, L. Farioli, A. M. Calamari, et al., “Lipid Transfer Protein Is the Major Maize Allergen Maintaining IgE-Binding Activity after Cooking at 100?C, as Demonstrated in Anaphylactic Patients and Patients with Positive Double-Blind, Placebo-Controlled Food Challenge Results,” Journal of Allergy and Clinical Immunology, Vol. 112, No. 4, 2003, pp. 775-783. doi:10.1016/S0091-6749(03)01942-0
[27] E. A. Pastorello, L. Farioli, V. Pravettoni, C. Ortolani, D. Fortunato, et al., “Identification of Grape and Wine Allergens as an Endichitinase 4, a Lipid-Transfer Protein, and a Thaumatin,” Journal of Allergy and Clinical Immunology, Vol. 111, No. 2, 2003, pp. 350-359. doi:10.1067/mai.2003.35
[28] A. Urisu, K. Yamada, S. Masuda, H. Komada, E. Wada, et al., “16-Kilodalton Rice Protein Is One of the Major Allergens in Rice Grain Extract and Responsible for Cross-Allergenicity between Cereal Grains in the Poaceae Family,” International Archives of Allergy and Immunology, Vol. 96, No. 3, 1991, pp. 244-252. doi:10.1159/000235502
[29] J. M. Mondego, R. O. Vidal, M. F. Carazzolle, E. K. Tokuda, L. P. Parizzi, et al., “An EST-Based Analysis Identifies New Genes and Reveals Distinctive Gene Expression Features of Coffeaarabica and Coffeacanephora,” Bio Med Central Plant Biology, Vol. 11, 2011, p. 30. doi:10.1186/1471-2229-11-30
[30] H. V. Amorim and R. V. Josephson, “Water Soluble Protein and Nonprotein Components of Brazilian Green Coffee Beans,” Journal of Food Science, Vol. 40, No. 6, 1975, pp. 1179-1185. doi:10.1111/j.1365-2621.1975.tb01047.x
[31] H. Bade and H. Stegemann,“Protein Patterns of Coffee Beans. Characterization by One-and Two-Dimensional Electrophoresis,” Journalof Agronomyand Crop Science, Zeitschrift fur Ackerund Pflanzenbau, Vol. 151, No. 2, 1982, pp. 89-98.
[32] M. Lepelley, V. Mahesh, J. McCarthy, M. Rigoreau, D. Crouzillat, et al., “Characterization, High-Resolution Mapping and Differential Expression of Three Homologous PAL Genes in Coffea canephora Pierre (Rubiaceae),” Planta, Vol. 236, No. 1, 2012, pp. 313-326. doi:10.1007/s00425-012-1613-2
[33] S. B. Lehrer, R. M. Karr and J. E. Salvaggio, “Extraction and Analysis of Coffee Bean Allergens,” Clinical Allergy, Vol. 8, No. 3, 1978, pp. 217-226.
[34] K. Osterman, S. G. Johansson and O. Zetterstrom, “Diagnostic Tests in Allergy to Green Coffee,” Allergy, Vol. 40, No. 5, 1985, pp. 336-343.
[35] T. S.Sonnex, R. P. P. Dawber and T. J. Ryan, “Mucosal Contact Dermatitis Due to Instant Coffee,” Contact Dermatitis, Vol. 7, No. 6, 1981, pp. 298-300.
[36] R. Treudler, B. Tebbe and C. E. Orfanos, “Coexistence of Type I and Type IV Sensitization in Occupational Coffee Allergy,” Contact Dermatitis, Vol. 36, No. 2, 1997, p. 109.
[37] N. D. Freedman, Y. Park, C. C. Abnet, A. R. Hollenbeck and R. Sinha, “Association of Coffee Drinking with Total and Cause-Specific Mortality,” New England Journal of Medicine, Vol. 366, No. 20, 2012, pp. 1891-1904.
[38] M. Hvatum, L. Kanerud, R. H?llgren and P. Brandtzaeg. “The Gut-Joint Axis: Cross Reactive Food Antibodies in Rheumatoid Arthritis,” Gut, Vol. 55, No. 9, 2006, pp. 1240-1247.
[39] E. Sugai, A. Chernavsky, S. Pedreira, E. Smecuol, H, Vasquez, et al., “Bone-Specific Antibodies in Sera from Patients with Celiac Disease: Characterization and Implications in Osteoporosis,” Journal of Clinical Immunology, Vol. 22, No. 6, 2002, pp. 353-362.
[40] A. Frustaci, L. Cuoco, C.Chimenti, M. Pieroni, G. Fioravanti, et al., “Celiac Disease Associated with Autoimmune Myocarditis,” Circulation, Vol. 105, No. 22, 2002, pp. 2611-2618.
[41] M. Hadjivassiliou, M. Maki, D. S.Sanders, et al, “Auto-antibody Targeting of Brain and Intestinal Transglutaminase in Gluten Ataxia,” Neurology, Vol. 66, No. 3, 2006, pp. 373-377. doi:10.1212/01.wnl.0000196480.55601.3a
[42] A. Vojdani, T. O’Bryan, J. A. Green, J. McCandless, K. N. Woeller, et al., “Immune Response to Dietary Proteins, Gliadin and Cerebellar Peptides in Children with Autism,” Nutritional Neuroscience, Vol. 7, No. 3, 2004, pp. 151-161. doi:10.1080/10284150400004155
[43] A. Alaedini, H. Okamoto, C. Briani, K. Wollenberg, H. A. Shill, et al., “Immune Cross-Reactivity in Coeliac Disease: Anti-Gliadin Antibodies Bind to Neuronal Synapsin I,” Journal of Immunology, Vol. 178, No. 10, 2007, pp. 6590-6595.
[44] C. L. Ching, M. K. Jones and J. G. C. Kingham, “Celiac Disease and Autoimmune Thyroid Disease,” Clinical Medicine and Research, Vol. 5, No. 3, 2007, pp. 184-192.
[45] S. B?dvarsson, I. Jónsdóttir, J. Freysdóttir, J. N. Leonard, L. Fry, et al., “Dermatitis Herpetiformis—An Autoimmune Disease Due to Cross-Reaction between Dietary Glutenin and Dermal Elastin?” Scandinavian Journal of Immunology, Vol. 38, No. 6, 1993, pp. 546-550.
[46] D. B. Shor, O. Barzillai, M. Ram, D. Izhaky, B. S. Porat-Katz, et al., “Gluten Sensitivity in Multiple Sclerosis: Experimental Myth or Clinical Truth?” Annals of the New York Academy of Sciences, Vol. 1173, 2009, pp. 343-349.
[47] C. O’Leary, C. H. Walsh, P. Wieneke, P. O’Regan, B. Buckley, et al., “Coeliac Disease and Autoimmune Addison’s Disease: A Clinical Pitfall,” Quarterly Journal of Medicine, Vol. 95, No. 2, 2002, pp. 79-82.
[48] A. J. Naiyer, J. Shah, L. Hernandez, S. Y. Kim, E. J. Ciaccio, et al., “Tissue Transglutaminase Antibodies in Individuals with Coeliac Disease Bind to Thyroid Follicles and Extra Cellular Matrix and May Contribute to Thyroid Dysfunction,” Thyroid, Vol. 18, No. 11, 2008, pp. 1171-1178.
[49] C. Sategna-Guidetti, E. Franco, S. Martini and M. Bobbio, “Binding by Serum IgA Antibodies from Patients with Coeliac Disease to Monkey Heart Tissue,” Scandinavian Journal of Gastroenterology, Vol. 39, No. 6, 2004, pp. 540-543.
[50] E. V. Marietta, M. J. Camilleri, L. A. Castro, P. K. Krause, M. R. Pittelkow, et al., “Transglutaminase Autoantibodies in Dermatitis Herpetiformis and Coeliac Sprue,” Journal of Investigative Dermatology, Vol. 128, No. 2, 2008, pp. 332-335.
[51] V. Toscano, F. G. Conti, E. Anastasi, et al., “Importance of Gluten in the Induction of Endocrine Autoantibodies and Organ Dysfunction in Adolescent Coeliac Patients,” American Journal of Gastroenterology, Vol. 95, No. 7, 2000, pp. 1742-1748. doi:10.1111/j.1572-0241.2000.02187.x
[52] S. Metso, H. Hyytia-Ilmonen, K. Kaukinen, H. Huhtala, P. Jaatinen, et al., “Gluten-Free Diet and Autoimmune Thyroiditis in Patients with Coeliac Disease. A Prospective Controlled Study,” Scandinavian Journal of Gastroenterology, Vol. 47, No. 1, 2012, pp. 43-48. doi:10.3109/00365521.2011.639084
[53] K. B. Faulkner-Hogg, W. S. Selby and R. H. Loblay, “Dietary Analysis in Symptomatic Patients with Coeliac Disease on a Gluten-Free Diet: The Role of Trace Amounts of Gluten and Non-Gluten Food Intolerance,” Scandinavian Journal of Gastroenterology, Vol. 34, No. 8, 1999, pp. 784-789. doi:10.1080/003655299750025714

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.